| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulysin | 26 | 2019 | 65 | 5.600 |
Why?
|
| Adenylyl Cyclases | 43 | 2015 | 105 | 4.910 |
Why?
|
| Bacillus anthracis | 22 | 2019 | 73 | 2.980 |
Why?
|
| Bacterial Toxins | 28 | 2019 | 113 | 2.660 |
Why?
|
| Calmodulin | 16 | 2015 | 50 | 2.470 |
Why?
|
| Antigens, Bacterial | 27 | 2019 | 135 | 1.960 |
Why?
|
| Models, Molecular | 37 | 2020 | 1371 | 1.840 |
Why?
|
| Protein Conformation | 22 | 2020 | 913 | 1.420 |
Why?
|
| Insulin | 11 | 2018 | 1216 | 1.410 |
Why?
|
| Protein Binding | 27 | 2020 | 1540 | 1.300 |
Why?
|
| Bacterial Proteins | 6 | 2020 | 893 | 1.280 |
Why?
|
| Anthrax | 8 | 2019 | 31 | 1.270 |
Why?
|
| Chemokine CCL3 | 3 | 2016 | 13 | 1.250 |
Why?
|
| Crystallography, X-Ray | 20 | 2018 | 528 | 1.100 |
Why?
|
| Amino Acid Sequence | 31 | 2019 | 2003 | 1.070 |
Why?
|
| Serine Endopeptidases | 2 | 2019 | 154 | 0.970 |
Why?
|
| Mitochondrial Proteins | 2 | 2019 | 129 | 0.950 |
Why?
|
| Molecular Sequence Data | 32 | 2015 | 2896 | 0.930 |
Why?
|
| Amyloid beta-Peptides | 8 | 2018 | 250 | 0.830 |
Why?
|
| Escherichia coli | 10 | 2015 | 569 | 0.810 |
Why?
|
| Protein Structure, Tertiary | 15 | 2015 | 731 | 0.790 |
Why?
|
| Immunoglobulin Fab Fragments | 3 | 2019 | 87 | 0.770 |
Why?
|
| Chemokine CCL4 | 2 | 2015 | 10 | 0.770 |
Why?
|
| Binding Sites | 19 | 2016 | 1145 | 0.730 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2020 | 203 | 0.720 |
Why?
|
| Metalloproteases | 3 | 2020 | 10 | 0.700 |
Why?
|
| Cyclic AMP | 13 | 2019 | 276 | 0.700 |
Why?
|
| Small Molecule Libraries | 2 | 2019 | 73 | 0.680 |
Why?
|
| Membrane Glycoproteins | 3 | 2020 | 445 | 0.640 |
Why?
|
| Proteolysis | 4 | 2018 | 126 | 0.640 |
Why?
|
| Glucosyltransferases | 2 | 2020 | 26 | 0.630 |
Why?
|
| Cysteine | 3 | 2009 | 147 | 0.620 |
Why?
|
| Scattering, Small Angle | 5 | 2020 | 37 | 0.610 |
Why?
|
| Structure-Activity Relationship | 13 | 2019 | 425 | 0.610 |
Why?
|
| Adenosine Triphosphate | 5 | 2011 | 314 | 0.590 |
Why?
|
| Adenylate Cyclase Toxin | 6 | 2009 | 14 | 0.590 |
Why?
|
| Substrate Specificity | 9 | 2014 | 368 | 0.590 |
Why?
|
| Peptides | 5 | 2014 | 664 | 0.580 |
Why?
|
| Benzimidazoles | 1 | 2019 | 116 | 0.570 |
Why?
|
| Adenylyl Cyclase Inhibitors | 7 | 2004 | 11 | 0.560 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 212 | 0.550 |
Why?
|
| Actin Cytoskeleton | 1 | 2020 | 198 | 0.540 |
Why?
|
| Protein Multimerization | 5 | 2020 | 191 | 0.540 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 166 | 0.540 |
Why?
|
| Enzyme Inhibitors | 7 | 2019 | 639 | 0.540 |
Why?
|
| Protein Structure, Secondary | 9 | 2014 | 340 | 0.490 |
Why?
|
| GTP-Binding Proteins | 9 | 1999 | 150 | 0.490 |
Why?
|
| Chemokine CCL5 | 1 | 2016 | 15 | 0.480 |
Why?
|
| Glycosaminoglycans | 1 | 2016 | 31 | 0.480 |
Why?
|
| Colforsin | 7 | 1998 | 68 | 0.460 |
Why?
|
| Chemokines, CC | 1 | 2015 | 36 | 0.440 |
Why?
|
| Exotoxins | 4 | 2005 | 21 | 0.440 |
Why?
|
| Catalytic Domain | 10 | 2015 | 163 | 0.430 |
Why?
|
| Amyloid | 3 | 2010 | 104 | 0.430 |
Why?
|
| Enzyme Activation | 13 | 2009 | 674 | 0.420 |
Why?
|
| Cell Line | 14 | 2019 | 2478 | 0.410 |
Why?
|
| Ubiquitin | 2 | 2013 | 95 | 0.410 |
Why?
|
| Cryoelectron Microscopy | 3 | 2020 | 119 | 0.400 |
Why?
|
| Animals | 48 | 2019 | 28471 | 0.400 |
Why?
|
| Amyloidogenic Proteins | 1 | 2013 | 21 | 0.400 |
Why?
|
| Calcium | 9 | 2009 | 1186 | 0.380 |
Why?
|
| Peptide Fragments | 6 | 2009 | 477 | 0.380 |
Why?
|
| Bordetella pertussis | 3 | 2009 | 15 | 0.370 |
Why?
|
| Viper Venoms | 4 | 2007 | 4 | 0.370 |
Why?
|
| Humans | 54 | 2019 | 96382 | 0.370 |
Why?
|
| Islet Amyloid Polypeptide | 4 | 2015 | 25 | 0.360 |
Why?
|
| Isoenzymes | 4 | 2004 | 272 | 0.360 |
Why?
|
| Cytoplasm | 3 | 2004 | 275 | 0.340 |
Why?
|
| Kinetics | 9 | 2018 | 1474 | 0.340 |
Why?
|
| Escherichia coli Proteins | 2 | 2004 | 183 | 0.330 |
Why?
|
| Natriuretic Peptides | 1 | 2010 | 7 | 0.330 |
Why?
|
| Recombinant Proteins | 12 | 2005 | 988 | 0.330 |
Why?
|
| Signal Transduction | 11 | 2014 | 3563 | 0.330 |
Why?
|
| Biocatalysis | 2 | 2019 | 55 | 0.330 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2019 | 110 | 0.320 |
Why?
|
| Mutation | 15 | 2020 | 4325 | 0.320 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2009 | 32 | 0.310 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2015 | 83 | 0.300 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 49 | 0.300 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 215 | 0.300 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2015 | 273 | 0.300 |
Why?
|
| Nitrogen | 1 | 2009 | 73 | 0.290 |
Why?
|
| Intestinal Diseases | 1 | 2010 | 84 | 0.290 |
Why?
|
| Pyrazoles | 2 | 2016 | 159 | 0.290 |
Why?
|
| Perforin | 1 | 2009 | 56 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2008 | 406 | 0.290 |
Why?
|
| Zinc | 2 | 2018 | 100 | 0.290 |
Why?
|
| Neprilysin | 1 | 2008 | 39 | 0.280 |
Why?
|
| X-Ray Diffraction | 3 | 2020 | 131 | 0.280 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2019 | 1937 | 0.280 |
Why?
|
| Catalysis | 7 | 2018 | 216 | 0.270 |
Why?
|
| Solubility | 6 | 2009 | 186 | 0.270 |
Why?
|
| Protein Subunits | 3 | 2005 | 121 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2015 | 1260 | 0.270 |
Why?
|
| Dimerization | 6 | 2016 | 149 | 0.270 |
Why?
|
| Protein Folding | 2 | 2009 | 291 | 0.270 |
Why?
|
| Mice | 20 | 2019 | 12495 | 0.260 |
Why?
|
| Ligands | 3 | 2020 | 484 | 0.260 |
Why?
|
| Protein Structure, Quaternary | 4 | 2015 | 105 | 0.250 |
Why?
|
| Cholesterol | 1 | 2009 | 372 | 0.250 |
Why?
|
| Molecular Structure | 6 | 2019 | 305 | 0.250 |
Why?
|
| Surface Plasmon Resonance | 4 | 2013 | 48 | 0.250 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 211 | 0.250 |
Why?
|
| Amino Acid Substitution | 4 | 2015 | 333 | 0.240 |
Why?
|
| CHO Cells | 4 | 2019 | 188 | 0.240 |
Why?
|
| Crystallization | 4 | 2017 | 215 | 0.230 |
Why?
|
| Intestinal Mucosa | 2 | 2010 | 829 | 0.230 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2014 | 403 | 0.230 |
Why?
|
| Alzheimer Disease | 4 | 2015 | 633 | 0.230 |
Why?
|
| Adenine | 2 | 2016 | 101 | 0.230 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 3 | 2004 | 21 | 0.220 |
Why?
|
| Oxygen | 1 | 2009 | 782 | 0.210 |
Why?
|
| Chromatography, Affinity | 2 | 2004 | 73 | 0.210 |
Why?
|
| Organophosphonates | 1 | 2004 | 46 | 0.200 |
Why?
|
| Thiazoles | 1 | 2004 | 126 | 0.200 |
Why?
|
| Hepatitis B, Chronic | 1 | 2004 | 36 | 0.200 |
Why?
|
| Imidazoles | 2 | 2014 | 142 | 0.200 |
Why?
|
| Cricetulus | 3 | 2019 | 123 | 0.190 |
Why?
|
| Polyomavirus | 4 | 1996 | 16 | 0.180 |
Why?
|
| Protein Domains | 2 | 2020 | 163 | 0.180 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 12 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2004 | 344 | 0.180 |
Why?
|
| Quinazolines | 1 | 2003 | 220 | 0.180 |
Why?
|
| DNA Mutational Analysis | 4 | 2016 | 546 | 0.170 |
Why?
|
| Chemotaxis | 2 | 2015 | 75 | 0.170 |
Why?
|
| Virus Replication | 4 | 1996 | 290 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 415 | 0.170 |
Why?
|
| Hydrolysis | 4 | 2014 | 142 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2004 | 369 | 0.170 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2000 | 9 | 0.170 |
Why?
|
| Glucagon | 2 | 2014 | 115 | 0.160 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2020 | 10 | 0.160 |
Why?
|
| Azoles | 1 | 2019 | 4 | 0.150 |
Why?
|
| Organoselenium Compounds | 1 | 2019 | 4 | 0.150 |
Why?
|
| Cricetinae | 5 | 2010 | 533 | 0.150 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1989 | 48 | 0.150 |
Why?
|
| Actins | 2 | 2020 | 473 | 0.150 |
Why?
|
| COS Cells | 1 | 2019 | 163 | 0.150 |
Why?
|
| Drug Repositioning | 1 | 2019 | 32 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 507 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2000 | 665 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 6 | 2015 | 3527 | 0.140 |
Why?
|
| Quantum Theory | 1 | 2018 | 41 | 0.140 |
Why?
|
| Tight Junctions | 2 | 2010 | 155 | 0.140 |
Why?
|
| Drug Design | 3 | 2010 | 135 | 0.140 |
Why?
|
| Sequence Alignment | 4 | 2005 | 351 | 0.130 |
Why?
|
| HIV Protease | 2 | 2007 | 10 | 0.130 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 189 | 0.130 |
Why?
|
| Asparagine | 1 | 1997 | 27 | 0.130 |
Why?
|
| DNA Replication | 5 | 1996 | 169 | 0.130 |
Why?
|
| Enzyme Activators | 2 | 2008 | 15 | 0.120 |
Why?
|
| Arginine | 1 | 1997 | 142 | 0.120 |
Why?
|
| Antigens | 1 | 2017 | 225 | 0.120 |
Why?
|
| Conserved Sequence | 2 | 2008 | 209 | 0.120 |
Why?
|
| Intestines | 2 | 2010 | 440 | 0.120 |
Why?
|
| Epidermis | 1 | 2016 | 105 | 0.120 |
Why?
|
| Focal Adhesions | 1 | 2016 | 66 | 0.110 |
Why?
|
| Alanine | 1 | 1995 | 82 | 0.110 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 149 | 0.110 |
Why?
|
| Leucine | 1 | 2015 | 57 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 53 | 0.110 |
Why?
|
| Methionine | 1 | 2015 | 64 | 0.110 |
Why?
|
| Guanosine Triphosphate | 3 | 2009 | 36 | 0.110 |
Why?
|
| Base Sequence | 8 | 2005 | 2219 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 304 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 100 | 0.110 |
Why?
|
| Carboxylic Acids | 1 | 2014 | 16 | 0.110 |
Why?
|
| Carbamates | 1 | 2014 | 15 | 0.110 |
Why?
|
| Triazoles | 1 | 2015 | 117 | 0.110 |
Why?
|
| Macromolecular Substances | 3 | 2004 | 162 | 0.110 |
Why?
|
| Oxadiazoles | 1 | 2014 | 37 | 0.110 |
Why?
|
| Models, Chemical | 2 | 2007 | 185 | 0.110 |
Why?
|
| Macrocyclic Compounds | 1 | 2014 | 8 | 0.110 |
Why?
|
| Retinal Neurons | 1 | 2014 | 11 | 0.100 |
Why?
|
| Cloning, Molecular | 5 | 2002 | 581 | 0.100 |
Why?
|
| Heart | 2 | 2007 | 526 | 0.100 |
Why?
|
| Acetates | 1 | 2014 | 60 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2016 | 408 | 0.100 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 128 | 0.100 |
Why?
|
| Serine | 3 | 2005 | 104 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 49 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2016 | 706 | 0.090 |
Why?
|
| Virulence Factors | 2 | 2011 | 115 | 0.090 |
Why?
|
| ortho-Aminobenzoates | 2 | 2009 | 5 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 653 | 0.090 |
Why?
|
| Cell Movement | 1 | 2016 | 810 | 0.090 |
Why?
|
| Transfection | 6 | 2005 | 881 | 0.090 |
Why?
|
| Cytosine Nucleotides | 1 | 2011 | 2 | 0.090 |
Why?
|
| Tyrosine | 3 | 2016 | 134 | 0.090 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 106 | 0.090 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 1997 | 11 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 408 | 0.080 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2010 | 10 | 0.080 |
Why?
|
| Protein Transport | 2 | 2010 | 441 | 0.080 |
Why?
|
| Polymerization | 1 | 2010 | 36 | 0.080 |
Why?
|
| Cyclic GMP | 1 | 2010 | 62 | 0.080 |
Why?
|
| Phosphorylation | 4 | 2016 | 1140 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 1248 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2009 | 945 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 82 | 0.080 |
Why?
|
| Apoproteins | 2 | 2007 | 22 | 0.080 |
Why?
|
| Dronabinol | 1 | 2011 | 59 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 661 | 0.080 |
Why?
|
| Amphetamine | 1 | 2011 | 101 | 0.080 |
Why?
|
| Mitochondria | 1 | 2014 | 638 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 1989 | 35 | 0.080 |
Why?
|
| S-Nitrosoglutathione | 1 | 2009 | 10 | 0.080 |
Why?
|
| Reactive Nitrogen Species | 1 | 2009 | 9 | 0.080 |
Why?
|
| Respiratory Burst | 1 | 2009 | 19 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2007 | 76 | 0.080 |
Why?
|
| Drosophila | 1 | 2014 | 543 | 0.080 |
Why?
|
| Static Electricity | 1 | 2009 | 96 | 0.080 |
Why?
|
| Intermediate Filament Proteins | 1 | 2009 | 35 | 0.070 |
Why?
|
| Vimentin | 1 | 2009 | 47 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2014 | 527 | 0.070 |
Why?
|
| Ionomycin | 1 | 2009 | 19 | 0.070 |
Why?
|
| Intracellular Space | 1 | 2009 | 38 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 106 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2014 | 1633 | 0.070 |
Why?
|
| Bacteriocins | 1 | 2009 | 14 | 0.070 |
Why?
|
| Hemolysin Proteins | 1 | 2009 | 32 | 0.070 |
Why?
|
| Mutation, Missense | 2 | 2008 | 300 | 0.070 |
Why?
|
| Anthrax Vaccines | 1 | 2008 | 2 | 0.070 |
Why?
|
| Occludin | 1 | 2009 | 66 | 0.070 |
Why?
|
| Pyrimidine Nucleotides | 1 | 2008 | 7 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2528 | 0.070 |
Why?
|
| Kallidin | 1 | 2008 | 6 | 0.070 |
Why?
|
| Purine Nucleotides | 1 | 2008 | 22 | 0.070 |
Why?
|
| Alkylation | 1 | 2008 | 31 | 0.070 |
Why?
|
| Reference Standards | 1 | 2009 | 145 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2009 | 172 | 0.070 |
Why?
|
| Maleimides | 1 | 2008 | 26 | 0.070 |
Why?
|
| Permeability | 1 | 2009 | 144 | 0.070 |
Why?
|
| Models, Biological | 3 | 2009 | 1792 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2009 | 98 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 328 | 0.070 |
Why?
|
| Hemorrhage | 2 | 2007 | 294 | 0.070 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2008 | 44 | 0.070 |
Why?
|
| Microglia | 1 | 2009 | 131 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2008 | 90 | 0.070 |
Why?
|
| Sulfhydryl Compounds | 1 | 2008 | 67 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1988 | 294 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 1 | 2011 | 240 | 0.070 |
Why?
|
| Gene Expression | 4 | 2002 | 1313 | 0.070 |
Why?
|
| Consensus | 1 | 2009 | 304 | 0.070 |
Why?
|
| EF Hand Motifs | 1 | 2007 | 1 | 0.070 |
Why?
|
| DNA, Viral | 4 | 1996 | 237 | 0.070 |
Why?
|
| HIV Protease Inhibitors | 1 | 2007 | 21 | 0.070 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 56 | 0.070 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 52 | 0.060 |
Why?
|
| Telomere-Binding Proteins | 1 | 2007 | 14 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2007 | 88 | 0.060 |
Why?
|
| Herpesvirus 3, Human | 1 | 2007 | 23 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 460 | 0.060 |
Why?
|
| Molecular Conformation | 2 | 2004 | 112 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 2007 | 74 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 1987 | 59 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2008 | 182 | 0.060 |
Why?
|
| Rats | 6 | 2011 | 4051 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2007 | 80 | 0.060 |
Why?
|
| Cattle | 4 | 2008 | 397 | 0.060 |
Why?
|
| Shock | 1 | 2007 | 55 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 516 | 0.060 |
Why?
|
| Software | 2 | 2018 | 684 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2007 | 136 | 0.060 |
Why?
|
| HIV-1 | 1 | 2007 | 178 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2007 | 205 | 0.060 |
Why?
|
| Point Mutation | 2 | 1998 | 237 | 0.060 |
Why?
|
| RNA, Viral | 1 | 1987 | 287 | 0.060 |
Why?
|
| Spodoptera | 2 | 2004 | 33 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2005 | 34 | 0.060 |
Why?
|
| Casein Kinase Ialpha | 1 | 2005 | 1 | 0.060 |
Why?
|
| Structural Homology, Protein | 1 | 2005 | 19 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2011 | 1242 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 800 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2011 | 101 | 0.060 |
Why?
|
| Nucleotides | 1 | 2005 | 93 | 0.060 |
Why?
|
| Receptors, Antigen | 1 | 2005 | 13 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2005 | 811 | 0.060 |
Why?
|
| Endopeptidase K | 1 | 2004 | 12 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 4 | 2011 | 1107 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2009 | 705 | 0.050 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2004 | 23 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2004 | 118 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2009 | 456 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2007 | 2845 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2015 | 238 | 0.050 |
Why?
|
| Diphosphates | 1 | 2004 | 15 | 0.050 |
Why?
|
| Coenzymes | 1 | 2004 | 5 | 0.050 |
Why?
|
| Peptide Library | 2 | 2017 | 86 | 0.050 |
Why?
|
| Cytokines | 2 | 2005 | 883 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2007 | 489 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 124 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 308 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 1988 | 1124 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 97 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2009 | 1278 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 136 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 217 | 0.050 |
Why?
|
| Scattering, Radiation | 1 | 2003 | 122 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 890 | 0.050 |
Why?
|
| Dogs | 2 | 2002 | 636 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2007 | 662 | 0.050 |
Why?
|
| Amino Acids | 2 | 2007 | 246 | 0.050 |
Why?
|
| Genetic Vectors | 2 | 2002 | 426 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1805 | 0.050 |
Why?
|
| Magnesium | 1 | 2002 | 171 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 274 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 1989 | 2005 | 0.050 |
Why?
|
| Species Specificity | 2 | 2008 | 688 | 0.050 |
Why?
|
| Isopropyl Thiogalactoside | 1 | 2002 | 3 | 0.040 |
Why?
|
| Membranes | 1 | 2002 | 35 | 0.040 |
Why?
|
| Light | 1 | 2003 | 290 | 0.040 |
Why?
|
| Cell Membrane | 3 | 2013 | 663 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2005 | 1301 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2004 | 417 | 0.040 |
Why?
|
| Naphthalenesulfonates | 1 | 2000 | 1 | 0.040 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 2839 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 554 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2000 | 80 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2005 | 544 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 1996 | 238 | 0.040 |
Why?
|
| Male | 7 | 2015 | 46116 | 0.040 |
Why?
|
| Apoptosis | 4 | 2011 | 1731 | 0.040 |
Why?
|
| DNA Primers | 2 | 2014 | 530 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2000 | 325 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2004 | 1148 | 0.040 |
Why?
|
| Isoindoles | 1 | 2019 | 13 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2000 | 209 | 0.040 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 1999 | 121 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 64 | 0.040 |
Why?
|
| Genes, Viral | 2 | 1989 | 101 | 0.030 |
Why?
|
| Transcription Factors | 3 | 2005 | 1698 | 0.030 |
Why?
|
| Baculoviridae | 3 | 1994 | 33 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 562 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2008 | 287 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1997 | 64 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1999 | 347 | 0.030 |
Why?
|
| Guanylate Cyclase | 1 | 1997 | 19 | 0.030 |
Why?
|
| Forecasting | 1 | 1998 | 292 | 0.030 |
Why?
|
| Female | 6 | 2016 | 50528 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 125 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 520 | 0.030 |
Why?
|
| Water | 1 | 2018 | 310 | 0.030 |
Why?
|
| src Homology Domains | 1 | 2016 | 45 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1996 | 14 | 0.030 |
Why?
|
| Peroxidases | 1 | 1996 | 33 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2017 | 154 | 0.030 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2016 | 31 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1996 | 30 | 0.030 |
Why?
|
| Adrenal Glands | 2 | 2007 | 72 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2016 | 22 | 0.030 |
Why?
|
| Brain | 3 | 1999 | 2415 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 1996 | 94 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 84 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2016 | 70 | 0.030 |
Why?
|
| Neoplasms | 2 | 2008 | 3271 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2015 | 48 | 0.030 |
Why?
|
| Microtubules | 1 | 2016 | 138 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 1995 | 38 | 0.030 |
Why?
|
| Keratinocytes | 1 | 2016 | 152 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 172 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 196 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 414 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 312 | 0.030 |
Why?
|
| Mammals | 1 | 1997 | 266 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 780 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 281 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2017 | 300 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 466 | 0.030 |
Why?
|
| Imaginal Discs | 1 | 2014 | 12 | 0.030 |
Why?
|
| Gastric Emptying | 1 | 2014 | 26 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 829 | 0.030 |
Why?
|
| Thinness | 1 | 2014 | 47 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 458 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 139 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2014 | 187 | 0.030 |
Why?
|
| Wound Healing | 1 | 2016 | 378 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.020 |
Why?
|
| Cell Survival | 2 | 2007 | 1012 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 316 | 0.020 |
Why?
|
| Cell Separation | 1 | 2013 | 200 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 435 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 178 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 554 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 635 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 1026 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 631 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1991 | 126 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 718 | 0.020 |
Why?
|
| Luminescence | 1 | 2011 | 20 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2011 | 73 | 0.020 |
Why?
|
| Apomorphine | 1 | 2011 | 8 | 0.020 |
Why?
|
| Lepidoptera | 1 | 1991 | 16 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2011 | 162 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2011 | 52 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2011 | 28 | 0.020 |
Why?
|
| Manganese | 1 | 1991 | 58 | 0.020 |
Why?
|
| Inhalation Exposure | 1 | 2011 | 35 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 706 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 50 | 0.020 |
Why?
|
| Self Administration | 1 | 2011 | 77 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 579 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 375 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2011 | 115 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 84 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 1989 | 17 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 901 | 0.020 |
Why?
|
| Isomerism | 1 | 2009 | 27 | 0.020 |
Why?
|
| Nestin | 1 | 2009 | 17 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2009 | 16 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1504 | 0.020 |
Why?
|
| Adenylyl Imidodiphosphate | 1 | 2008 | 3 | 0.020 |
Why?
|
| Factor X | 1 | 2008 | 3 | 0.020 |
Why?
|
| Bacillus cereus | 1 | 2008 | 9 | 0.020 |
Why?
|
| Prothrombin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 2008 | 24 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 58 | 0.020 |
Why?
|
| Quorum Sensing | 1 | 2008 | 29 | 0.020 |
Why?
|
| Paraffin Embedding | 1 | 2008 | 77 | 0.020 |
Why?
|
| Microfluidics | 1 | 2008 | 59 | 0.020 |
Why?
|
| DNA | 2 | 1991 | 1270 | 0.020 |
Why?
|
| Phenotype | 2 | 1999 | 2602 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2007 | 65 | 0.020 |
Why?
|
| Skin | 1 | 2011 | 583 | 0.020 |
Why?
|
| Epitopes | 1 | 2008 | 252 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 40 | 0.020 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2007 | 1 | 0.020 |
Why?
|
| Ion Channels | 1 | 1989 | 258 | 0.020 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2007 | 8 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2007 | 41 | 0.020 |
Why?
|
| Obesity | 1 | 2014 | 1044 | 0.020 |
Why?
|
| Receptors, Peptide | 1 | 2007 | 32 | 0.020 |
Why?
|
| Corticosterone | 1 | 2007 | 35 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2007 | 146 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 79 | 0.020 |
Why?
|
| Edema | 1 | 2007 | 68 | 0.020 |
Why?
|
| Antibodies | 1 | 2008 | 347 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2007 | 207 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2007 | 199 | 0.010 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2005 | 7 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2005 | 54 | 0.010 |
Why?
|
| Concanavalin A | 1 | 2005 | 46 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2348 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2005 | 85 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2005 | 58 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2005 | 122 | 0.010 |
Why?
|
| Cell Shape | 1 | 2005 | 50 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2005 | 71 | 0.010 |
Why?
|
| Multiple Organ Failure | 1 | 2005 | 63 | 0.010 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 18 | 0.010 |
Why?
|
| Spindle Apparatus | 1 | 2005 | 66 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2005 | 112 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 217 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 355 | 0.010 |
Why?
|
| Cytosol | 1 | 2005 | 192 | 0.010 |
Why?
|
| Ileum | 1 | 2005 | 169 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2494 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 151 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 109 | 0.010 |
Why?
|
| Histidine | 1 | 2005 | 69 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 2004 | 22 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 522 | 0.010 |
Why?
|
| Metals | 1 | 2005 | 102 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2005 | 165 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2005 | 268 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2004 | 41 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 415 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 98 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 518 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2005 | 482 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1996 | 34 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 482 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 1372 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 607 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2003 | 238 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 310 | 0.010 |
Why?
|
| Myocardium | 1 | 2005 | 574 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 271 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5524 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 810 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1768 | 0.010 |
Why?
|
| Lung | 1 | 2007 | 1389 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 759 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 1114 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 631 | 0.010 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 1999 | 9 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 1999 | 17 | 0.010 |
Why?
|
| Carbachol | 1 | 1999 | 34 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 1999 | 138 | 0.010 |
Why?
|
| Glycine | 1 | 1999 | 95 | 0.010 |
Why?
|
| Oocytes | 1 | 1999 | 212 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 2164 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1999 | 404 | 0.010 |
Why?
|
| Oncogene Proteins v-fos | 1 | 1996 | 3 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 28794 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 1996 | 13 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3221 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1994 | 25 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1994 | 31 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1994 | 119 | 0.010 |
Why?
|
| Insecta | 1 | 1994 | 57 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1994 | 273 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 380 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1989 | 195 | 0.000 |
Why?
|
| Adult | 1 | 2008 | 28968 | 0.000 |
Why?
|